Clinical Trial Update: Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)

View source ↗

Summary

Trial INBERNAV-Neo is a prospective study sponsored by Biobizkaia Health Research Institute to reduce the incidence of nosocomial infections in neonatal units, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthcare-associated Infections
• Neonatal Pneumonia
• Ventilator-associated Pneumonia

Snippet

Sponsor: Biobizkaia Health Research Institute | Conditions: Pneumonia Ventilator Associated, Pneumonia Neonatal | Status: RECRUITING